The Basics of In Vitro Xenobiotic Metabolism and Drug-Drug Interaction Investigations: Applicability to All Xenobiotics
Since SOT’s 59th Annual Meeting and ToxExpo has been canceled due to COVID-19 concerns, we are bringing the tradeshow to you! SOT is hosting this course virtually on April 3rd from 12-3:30pm EDT. Our VP of Consulting, Dr. Brian Ogilvie, will be conducting the workshop alongside our founder, Andrew Parkinson, and an excellent list of presenters including:
- Introductory Remarks on Xenobiotic Metabolism and Course Overview – Andrew Parkinson, XPD Consulting
- The Basics of In Vitro CYP Inhibition Studies for Regulatory Submission and Risk Assessment – Brian Ogilvie, XenoTech
- The Basics of In Vitro CYP Induction Studies for Regulatory Submission – Diane Ramsden, Alnylam Pharmaceuticals
- In Vitro Reaction Phenotyping and the Toxicological Burden of Reactive Metabolites – Jed Lampe, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
- Xenobiotic Transporter Studies for Regulatory Submission – Caroline Lee, Arena Pharmaceuticals
- The Science of Drug Interactions Is Applicable to All Xenobiotics – Andrew Parkinson, XPD Consulting
If you cannot attend, a recording of the virtual course will become available to registrants on SOT’s website approximately 1 week after the event. The course number for the workshop is AM07.
Register through SOT to view webinar & Download slides
What topic would you like to hear about?
Our experts are constantly on the hunt for new and exciting topics to present on, and nothing helps us figure out what you want to hear more than requests and feedback! Use our form to submit your request so we can continue producing educational materials you look forward to
